AG
CRL icon

Advisor Group’s Charles River Laboratories CRL Stock Holding History

Advisor Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$802K Buy
5,241
+561
+12% +$77.7K 0.01% 1348
2019
Q3 		$619K Buy
4,680
+204
+5% +$27.4K ﹤0.01% 1453
2019
Q2 		$636K Buy
4,476
+236
+6% +$32K ﹤0.01% 1448
2019
Q1 		$616K Sell
4,240
-234
-5% -$30.7K 0.01% 1446
2018
Q4 		$507K Sell
4,474
-139
-3% -$17.4K 0.01% 1397
2018
Q3 		$621K Buy
4,613
+2,470
+115% +$305K 0.01% 1310
2018
Q2 		$240K Buy
2,143
+60
+3% +$6.49K ﹤0.01% 1835
2018
Q1 		$222K Buy
2,083
+60
+3% +$6.47K ﹤0.01% 1895
2017
Q4 		$221K Buy
2,023
+485
+32% +$52.8K ﹤0.01% 1910
2017
Q3 		$165K Buy
1,538
+945
+159% +$97.1K ﹤0.01% 1996
2017
Q2 		$60K Buy
593
+230
+63% +$21.2K ﹤0.01% 2694
2017
Q1 		$33K Buy
363
+150
+70% +$12.7K ﹤0.01% 3010
2016
Q4 		$16K Buy
213
+4
+2% +$304 ﹤0.01% 3350
2016
Q3 		$17K Sell
209
-20
-9% -$1.68K ﹤0.01% 3244
2016
Q2 		$18K Buy
+229
New +$18.9K ﹤0.01% 3126

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Advisor Group's CRL Position: Q4 2019 in Review

Advisor Group increased its Charles River Laboratories (CRL) stake by 12% in Q4 2019, buying an estimated $77.7K and bringing the position to 5,241 shares worth $802K. The position accounts for 0.01% of the portfolio, ranked #1348.

Advisor Group first reported a position in CRL in Q2 2016 and has held it in 15 quarters since. 413 funds tracked by Wall St. Rank hold CRL as of Q4 2019.

  • Advisor Group held 5,241 shares of Charles River Laboratories worth $802K as of Q4 2019.
  • Advisor Group bought 561 Charles River Laboratories shares in Q4 2019, an estimated $77.7K.
  • Charles River Laboratories made up 0.01% of Advisor Group's portfolio in Q4 2019, its #1348 holding.
  • Advisor Group first reported a position in Charles River Laboratories in Q2 2016 and has held it in 15 quarters since.
  • 413 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.